查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1618721

肌红蛋白市场：按类型、检测方法和最终用户划分 - 2025-2030 年全球预测

Myoglobin Market by Type (Animal, Human), Detection Method (Enzyme-Linked Immunosorbent Assay, Immunohistochemistry, Mass Spectrometry), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年肌红蛋白市场价值为9,741万美元，预计2024年将达到1,0107万美元，复合年增长率为3.91%，预计到2030年将达到12,749万美元。

肌红蛋白是一种含血红素的蛋白质，主要因其在肌肉组织中运输和储存氧气的作用而被认可。它在医学诊断和研究中极为重要，特别是因为它可以及早发现肌肉损伤和心肌梗塞等疾病。对肌红蛋白的需求是因为它的高敏感性和在肌肉损伤后快速释放到血液中，这使得它在临床环境中对于及时诊断非常有价值。其应用不仅限于医学，还用于科学研究、监测运动员的运动医学以及食品工业中的肉类品质评估。最终用途范围包括医院、诊断实验室、研究机构、食品加工公司等。

主要市场统计
基准年[2023] 9741万美元
预测年份 [2024] 10107万美元
预测年份 [2030] 1.2749亿美元
复合年增长率（%） 3.91%

市场洞察表明，心血管疾病盛行率的增加和健康意识的提高是肌红蛋白市场的主要成长动力。生物技术应用的扩大和研发投资的增加进一步推动了市场的扩张。关键机会存在于就地检验解决方案的进步和新型诊断分析的开发中，特别是在医疗基础设施投资不断增加的新兴市场。然而，来自替代生物标记的竞争、监管障碍和检测成本上升等挑战可能会阻碍市场成长。由于技术障碍和测试结果的可变性，它们还面临限制，并且需要在检测灵敏度和特异性方面进行创新以提高诊断准确性。

需要创新的领域包括开发具有成本效益的快速诊断设备、将人工智慧整合到诊断中进行预测分析，以及透过肌红蛋白变体的生物工程来提高食品行业的肉类品质等。个人化医疗和精准诊断的研究进展预示着进一步的成长。市场的本质是动态的，由技术进步驱动，创新对于保持竞争优势至关重要。鼓励相关人员投资强有力的研究合作并使其应用组合多样化，以有效克服挑战并利用新机会。

市场动态：揭示快速发展的肌红蛋白市场的关键市场见解

供给和需求的动态交互作用正在改变肌红蛋白市场。了解这些不断变化的市场动态可以帮助组织做出明智的投资决策、改善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 心血管疾病患者数量的增加以及对有效诊断和治疗解决方案的需求
    • 扩大生物技术研究的投资和伙伴关係
  • 市场限制因素
    • 与肌红蛋白相关的严格监管要求
  • 市场机会
    • 在临床测试和实验室中广泛采用
    • 肉类产业颜色参数控制的新用途
  • 市场问题
    • 与肌红蛋白萃取相关的复杂性

波特的五力：驾驭肌红蛋白市场的策略工具

波特的五力框架是了解肌红蛋白市场竞争格局的关键工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解肌红蛋白市场的外部影响

外部宏观环境因素在塑造肌红蛋白市场的表现动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解肌红蛋白市场的竞争格局

肌红蛋白市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：肌红蛋白市场供应商的绩效评估

FPNV定位矩阵是评估肌红蛋白市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製肌红蛋白市场的成功之路

对于想要加强在全球市场的影响力的公司来说，肌红蛋白市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争格局中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境，主要企业的广泛资料，评估其在市场中的影响力和整体影响力。

2. 市场开发：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、未开发地区、主要产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 心血管疾病的增加以及对有效诊断和治疗解决方案的需求
      • 扩大生物技术研究的投资和合作伙伴关係
    • 抑制因素
      • 与肌红蛋白相关的严格监管要求
    • 机会
      • 在临床测试和实验室中广泛采用
      • 控制肉品产业颜色参数的新应用
    • 任务
      • 与肌红蛋白萃取相关的复杂性
  • 市场区隔分析
    • 类型：利用动物性肌红蛋白进行研究和创新，以满足未满足的患者需求
    • 最终用户：在诊断实验室中更多地使用肌红蛋白来识别与肌肉相关的损伤
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章肌红蛋白市场：依类型

  • 介绍
  • 动物
  • 人类

第七章 肌红蛋白市场：依检测方法

  • 介绍
  • 酵素免疫分析法
  • 免疫组织化学
  • 质谱分析
  • 蛋白质印迹法

第 8 章 肌红蛋白市场：依最终用户分类

  • 介绍
  • 诊断实验室
  • 医院/诊所
  • 製药和生物技术公司
  • 研究所

第 9 章美洲肌红蛋白市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太肌红蛋白市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的肌红蛋白市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • CytoSorbents 获得 TFDA核准在中国销售 CytoSorb
    • 比利时Start-UpsPaleo 使用精密发酵技术生产酵母肌红蛋白
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • BBI Solutions
  • Bio Rad Laboratories Inc.
  • Bio SB, Inc.
  • bioMerieux SA
  • Boditech Med Inc.
  • DiaSorin SpA
  • DiaSys Diagnostic Systems GmbH
  • F. Hoffmann-La Roche AG
  • GenScript
  • Horiba, Ltd.
  • Leica Biosystems Nussloch GmbH
  • Merck KGaA
  • OriGene Technologies, Inc.
  • PerkinElmer Inc.
  • Randox Laboratories Ltd.
  • Scripps Laboratories Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Tosoh Corporation
Product Code: MRR-62667ADF95CC

The Myoglobin Market was valued at USD 97.41 million in 2023, expected to reach USD 101.07 million in 2024, and is projected to grow at a CAGR of 3.91%, to USD 127.49 million by 2030.

Myoglobin is a heme-containing protein primarily recognized for its role in transporting and storing oxygen in muscle tissues. It is pivotal in medical diagnostics and research, particularly for its early detection capabilities of muscle injury and conditions such as myocardial infarction. The necessity of myoglobin stems from its high sensitivity and rapid release into the bloodstream following muscle damage, making it invaluable in clinical settings for timely diagnosis. Its applications extend beyond healthcare, being utilized in scientific research, sports medicine for monitoring athletes, and the food industry for meat quality assessment. The end-use scope includes hospitals, diagnostic laboratories, research institutes, and food processing companies.

KEY MARKET STATISTICS
Base Year [2023] USD 97.41 million
Estimated Year [2024] USD 101.07 million
Forecast Year [2030] USD 127.49 million
CAGR (%) 3.91%

Market insights reveal that the growing prevalence of cardiovascular diseases and increasing health awareness are significant growth drivers for the myoglobin market. The expanding applications in biotechnology and increasing investments in research and development further fuel market expansion. Key opportunities exist in advancing point-of-care testing solutions and developing novel diagnostic assays, especially in emerging markets with rising healthcare infrastructure investments. However, challenges such as competition from alternative biomarkers, regulatory hurdles, and high costs of testing can impede market growth. The market also faces limitations from technological barriers and variability in test results, which demand innovations in assay sensitivity and specificity to enhance diagnostic accuracy.

Areas ripe for innovation include developing cost-effective and faster diagnostic devices, integrating artificial intelligence for predictive analytics in diagnostics, and enhancing the bioengineering of myoglobin variants for improved meat quality in the food industry. Research advancements in personalized medicine and precision diagnostics present further growth avenues. The market's nature is dynamic, driven by technological advancements, with innovation being crucial for maintaining competitive advantage. Stakeholders are recommended to invest in robust research collaborations and diversify application portfolios to navigate challenges effectively and leverage emerging opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Myoglobin Market

The Myoglobin Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing cases of cardiovascular diseases and the need for effective diagnostic and therapeutic solutions
    • Growing investments and partnerships in biotechnological research
  • Market Restraints
    • Strict regulatory requirements associated with the myoglobin
  • Market Opportunities
    • Significant adoption in clinical trials and research laboratories
    • Emerging usage in meat industries to control color parameter
  • Market Challenges
    • Complexities associated with the extraction of myoglobin

Porter's Five Forces: A Strategic Tool for Navigating the Myoglobin Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Myoglobin Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Myoglobin Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Myoglobin Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Myoglobin Market

A detailed market share analysis in the Myoglobin Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Myoglobin Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Myoglobin Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Myoglobin Market

A strategic analysis of the Myoglobin Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Myoglobin Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, BBI Solutions, Bio Rad Laboratories Inc., Bio SB, Inc., bioMerieux S.A., Boditech Med Inc., DiaSorin S.p.A, DiaSys Diagnostic Systems GmbH, F. Hoffmann-La Roche AG, GenScript, Horiba, Ltd., Leica Biosystems Nussloch GmbH, Merck KGaA, OriGene Technologies, Inc., PerkinElmer Inc., Randox Laboratories Ltd., Scripps Laboratories Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., and Tosoh Corporation.

Market Segmentation & Coverage

This research report categorizes the Myoglobin Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Animal and Human.
  • Based on Detection Method, market is studied across Enzyme-Linked Immunosorbent Assay, Immunohistochemistry, Mass Spectrometry, and Western Blotting.
  • Based on End-User, market is studied across Diagnostic Laboratories, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing cases of cardiovascular diseases and the need for effective diagnostic and therapeutic solutions
      • 5.1.1.2. Growing investments and partnerships in biotechnological research
    • 5.1.2. Restraints
      • 5.1.2.1. Strict regulatory requirements associated with the myoglobin
    • 5.1.3. Opportunities
      • 5.1.3.1. Significant adoption in clinical trials and research laboratories
      • 5.1.3.2. Emerging usage in meat industries to control color parameter
    • 5.1.4. Challenges
      • 5.1.4.1. Complexities associated with the extraction of myoglobin
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Utilization of animal-based myoglobin in research and innovation to cater to unmet needs of patients
    • 5.2.2. End-User: Increasing usage of myoglobin in diagnostic laboratories for identification of muscle-related injuries
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Myoglobin Market, by Type

  • 6.1. Introduction
  • 6.2. Animal
  • 6.3. Human

7. Myoglobin Market, by Detection Method

  • 7.1. Introduction
  • 7.2. Enzyme-Linked Immunosorbent Assay
  • 7.3. Immunohistochemistry
  • 7.4. Mass Spectrometry
  • 7.5. Western Blotting

8. Myoglobin Market, by End-User

  • 8.1. Introduction
  • 8.2. Diagnostic Laboratories
  • 8.3. Hospitals & Clinics
  • 8.4. Pharmaceutical & Biotechnology Companies
  • 8.5. Research Institutes

9. Americas Myoglobin Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Myoglobin Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Myoglobin Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. CytoSorbents receives TFDA approval to distribute CytoSorb in China
    • 12.3.2. Belgian startup Paleo leverages precision fermentation to produce yeast-based myoglobin
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. BBI Solutions
  • 3. Bio Rad Laboratories Inc.
  • 4. Bio SB, Inc.
  • 5. bioMerieux S.A.
  • 6. Boditech Med Inc.
  • 7. DiaSorin S.p.A
  • 8. DiaSys Diagnostic Systems GmbH
  • 9. F. Hoffmann-La Roche AG
  • 10. GenScript
  • 11. Horiba, Ltd.
  • 12. Leica Biosystems Nussloch GmbH
  • 13. Merck KGaA
  • 14. OriGene Technologies, Inc.
  • 15. PerkinElmer Inc.
  • 16. Randox Laboratories Ltd.
  • 17. Scripps Laboratories Inc.
  • 18. Siemens Healthineers AG
  • 19. Thermo Fisher Scientific Inc.
  • 20. Tosoh Corporation

LIST OF FIGURES

  • FIGURE 1. MYOGLOBIN MARKET RESEARCH PROCESS
  • FIGURE 2. MYOGLOBIN MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MYOGLOBIN MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MYOGLOBIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MYOGLOBIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MYOGLOBIN MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MYOGLOBIN MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MYOGLOBIN MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MYOGLOBIN MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS MYOGLOBIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS MYOGLOBIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES MYOGLOBIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES MYOGLOBIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC MYOGLOBIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC MYOGLOBIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MYOGLOBIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MYOGLOBIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. MYOGLOBIN MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. MYOGLOBIN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MYOGLOBIN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MYOGLOBIN MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MYOGLOBIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MYOGLOBIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MYOGLOBIN MARKET DYNAMICS
  • TABLE 7. GLOBAL MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MYOGLOBIN MARKET SIZE, BY ANIMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MYOGLOBIN MARKET SIZE, BY HUMAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MYOGLOBIN MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MYOGLOBIN MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MYOGLOBIN MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MYOGLOBIN MARKET SIZE, BY WESTERN BLOTTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MYOGLOBIN MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MYOGLOBIN MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MYOGLOBIN MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MYOGLOBIN MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS MYOGLOBIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES MYOGLOBIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC MYOGLOBIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA MYOGLOBIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. MYOGLOBIN MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. MYOGLOBIN MARKET, FPNV POSITIONING MATRIX, 2023